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Abstract 
Complementary health approach use is growing over the past 15 years among cancer patients, either in Western 
countries or in the Far East or in developing countries. So it has undoubtedly gained medical, economic and 
research importance. Aim: to assess use, predictors and characteristics associated with use of complementary 
health approaches among patients with cancer. Research design: a descriptive exploratory research design will be 
utilized. Setting: the study was conducted in the Oncology and Nuclear medicine department affiliated to one of 
the University Hospital, Cairo-Egypt. Subjects: a convenient sample of 150 adult male and female cancer 
patients who fulfill the inclusion and exclusion criteria enrolled in the study. Tool: a 21-items questionnaire 
covering patient demographics features (6items), treatment-related variables (4items), characteristics and 
predictors of complementary health approach (11items) was used. Results: (67.3%) of the study sample used 
complementary health approaches in association with the conventional treatment of cancer, the most frequent 
used types of complementary health approach were herbal products, massage, and meditation. Characteristics of 
complementary health approach users were young age, male patients, those with decreased activity of daily 
living and patients with genitourinary and blood cancer; predictors of complementary health approach use were 
young age (18-30) (OR4.9 and p=0.010), decreased activity of daily living (OR .346 and p=0.033).Conclusion: 
patients living with cancer may be actively using a variety of complementary health approaches while also 
undergoing conventional cancer treatments. 
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1. Introduction 
Cancer patients have been turning to complementary health approaches (CHA) in ever increasing numbers 
over recent decades. Cancer is one of three leading causes of death in developing countries; associated with 
significant disabilities and is considered as a major public health problem. According to World Health 
Organization (WHO), it is expected that cancer rates will be doubled by 2030 (Abdelmoaty et al., 2018). 
 
Cancer patients and their families face the trauma of distress, worries and immense fear; they seek all possible 
options of effective treatment. Some patients also search for the CHA option. Complementary health approach 
is of critical importance to cancer patients. From an oncologist’s point of view, methods different from 
conventional treatments are critical as well, at least because of constant requests by patients and safety issues 
due to unknown interactions with classic anticancer therapeutics (Fremd et al., 2017). 
 
Complementary health approach (formerly referred to as complementary and alternative medicine) has been 
described as ‘‘diagnosis, treatment and/or prevention which complements mainstream medicine by 
contributing to a common whole, satisfying a demand not met by orthodoxy, or diversifying the conceptual 
frameworks of medicine’’, several factors are believed to contribute to the popularity of CHA; these can be 
broadly classified as “push” and “pull” factors. Among the pull factors (i.e. features that attract people to 
CHA are holistic healthcare beliefs, preference for active healthcare participation, positive past experience 
with a CHA practitioner, desire for an egalitarian healthcare provider and perceived safety and effectiveness 
of CHA(Deng & Latte-Naor, 2018). 
 
Hall et al., (2018) define CHA as ‘a diverse group of healthcare practices not generally considered part of the 
conventional medical curriculum , in addition  literature review explored modalities including (but not limited 
to) acupuncture, aromatherapy, Chinese medicine, chiropractic, homeopathy and naturopathy. 
 
Awareness of and interest in complementary therapies is increasing among patients with cancer hence the 
National Center for Complementary  Medicine (NCCM) characterizes five major types of these nontraditional 
therapies: whole medical systems (eg, naturopathy, traditional Chinese medicine); mind-body medicine (eg, 
meditation, prayer); biologically based practices (eg, vitamins, herbal products, nutritional supplements); 
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manipulative and body-based practices (eg, massage, chiropractic); and energy medicine(Letourneau, 2018). 
 
Considerable number of people is turning to complementary health approach. In the context of CHA use it has 
been suggested that people who use CHA either suffer from chronic conditions that might not have been 
treated satisfactorily by conventional medicine or have life-threatening diseases and use CHA because they 
are experiencing psychological distress and will try anything that might offer a cure ,in addition the motive for 
CHA use could be to reduce the side-effects of chemotherapy(Bishop & Lewith, 2010).Also; previous studies 
suggest that patient characteristics that are predictive of CHA cancer are generally younger and have higher 
socio-economic status, being female, being more highly educated and having poorer health status than non-
users(Pedersen, Christensen, Jensen, & Zachariae, 2009). 
 
Complementary health approach has become a popular form of healthcare and the predictions are that, it will 
increase further. The reasons for this level of popularity are highly diverse, and much of the motivation to turn 
to CHA pertains to a deeply felt criticism of mainstream medicine, many people (are led to) believe that 
conventional interventions, CHA optimizes supportive cancer care by offering non-pharmacologic approaches 
to symptoms of cancer and the heavy toxicities of its treatment, the practice of CHA is focused on improving 
the quality of life (QOL), optimal recovery, as well as promoting lifestyle changes that may reduce recurrence 
risks for some cancers (Sagar, 2008, Berretta et al., 2017). 
 
Patients who use CHA do so most often at opposite ends of the disease spectrum either for chronic, minor 
illnesses (e.g. back pain or arthritis) or devastating, life-threatening conditions (e.g. cancer or AIDS). In both 
situations, conventional options may be perceived as either ineffective or too toxic. Besides perceived 
therapeutic benefits, many complementary therapies not only have few unpleasant adverse effects, but also 
actually induce pleasant side effects. Reflexology, aromatherapy and massage, for instance, can be very 
relaxing. The aims of CHA may be closer to those of patients than of conventional healthcare professionals. 
While physicians usually want to alter the course of pathological processes, patients simply want to feel better 
(Frass et al., 2012). 
 
Cancer patients use CHA for disease-related symptoms, treatment-related adverse effects not addressed by 
conventional treatment,  such as recurring pain, insomnia, and ongoing psychological distress, also they seek to 
improve quality of life, its presumed anti-neoplastic or cancer preventive properties, its presumed pro-immune 
activity, and more control and responsibility of their own care (Stub et al., 2016). However, the CHA use and 
practices among cancer patients in Egypt are limited. This study therefore to assess use, predictors and 
characteristics associated with use of complementary health approaches among patients with cancer. 
 
Significance of the Study 
Patients and caregivers, whose lives have been touched by cancer, deal with enormous stressors over the 
course of their diagnosis, treatment through survivorship, or end-of-life care. Despite the high prevalence of, 
research suggests that patients often do not discuss CHA use with their conventional health care provider.  
However, little is known about the use of CHA in patients with cancer specifically, also the use of CHA has 
increased steadily over the past 15 years or so, and definitely it has gained medical, economic and sociological 
importance (Stub et al., 2016). 
 
Researchers observed through their clinical experience that large number of cancer patients utilize CHA 
without informing health care providers so a better examination of these topics is critical to develop better 
integration of CHA with conventional medical system and support patient-centered communication in cancer 
survivorship care in Egypt. Information on the use of CHA in patients with cancer is scarce. Given the disease 
and treatment complexities associated with the care of patients with cancer, oncology health care providers 
would benefit from having an appreciation of the extent of usage of unconventional, adjunctive therapies 
among these patients. This study evaluated the use, demographic and clinical predictors of CHA among 
patient with cancer. 
 
The present study will add additional information on prediction and frequency of CHA use and generate 
hypotheses. A comprehensive medical history is paramount for nurses in order to achieve quality care, but 
patients do not always inform healthcare professionals about CHA use which can lead to harmful double 
treatment or medication. The study also offers information for CHA providers on the medical backgrounds of 
their patients. They can utilize this information to ensure safe care and assess the need for biomedical care. 
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1.1 Aim of the study 
The aim of the current study was to assess use, predictors and characteristics associated with use of 
complementary   
health approaches among patients with cancer. 
1.2 Research Questions 
1. What is the frequency of CHA use among patients with cancer? 
2. What are the different CHA used among patients with cancer? 
3. What are the characteristics of CHA users among patients with cancer? 
4. What are the predictors for using CHA among patients with cancer? 
 
2. Methodology 
2.1 Research design 
Descriptive exploratory research design was utilized to achieve the aim of the current study.  
2.2 Setting 
The study was conducted in the Oncology and Nuclear medicine department affiliated to one of the University 
Hospital, Cairo-Egypt, during the period from November 2017 till June 2018. 
2.3 Sample 
A convenient sample of 150 adult male and female cancer patients who fulfill the inclusion and exclusion criteria 
enrolled in the study with the following inclusion and exclusion criteria. Inclusion Criteria: adult male and 
female cancer patients over or equal 18 years old and those who willing to participate in the study. Exclusion 
criteria: end of life patients, altered level of consciousness.  
2.4 Tools 
To achieve the aim of the current study the following questionnaire was used;   
The data collection instrument was a 21-item questionnaire was developed after an extensive literature review, 
covering patient demographic features and medical data (6items) as age, sex, educational level, diagnosis, 
duration of disease .Treatment -related variables (4items), as type of treatment from the start of the disease, type 
of treatment was taken during the study, Is the treatment effective and. variables related to characteristics and 
predictors of CHA use (11items) as motive for starting CHA, its cost , desired effect , side effect , information 
received and different types of CHA as herbal, message, yoga, prayer drawing ……..etc. On the cover page of 
the questionnaire, CHA was clearly defined as follows: “any therapy not included in the mainstream biomedical 
framework of care for patients. CHA means remedies that are used without the approval of the relevant 
government authorities, such as the Ministry of Health, that approve new drugs. CHA includes natural products, 
herbs, green tea, other special foods, megavitamins, acupuncture, aromatherapy, massage, meditation, and so on. 
The questionnaire was submitted to a panel of five experts in the field of Medical Surgical Nursing as well as 
Oncology and Nuclear Medicine to evaluate its content validity. Modifications were carried out according to 
expert’s judgments on clarity of sentences and appropriateness of the contents. Reliability was established using 
Cronbach’s α which showed a satisfactory level .The Cronbach’s alpha reliability has been reported as 0.84. 
 
2.5 Ethical considerations 
An official permission was obtained from the selected outpatient clinics’ administrators. At the initial interview, 
each potential participant was informed about the purpose, the procedure, and the benefits of the study, and a 
cover letter explaining the research project was also read to them. They were informed as well that participation 
in the study is completely voluntary and they have the right to withdraw from the study at any time without any 
penalty. Confidentiality and anonymity were assured too. 
 
2.6 Pilot Study 
A pilot study was conducted on 6 participants at the specified unit, and these participants were excluded from 
the main study sample. The objectives of the pilot study were to fill in the entire questionnaires and to clarify 
the questions (whether any question was unclear or ambiguous). Modifications were done for some 
mysterious statements, otherwise, almost all items were clearly understood and the responses were found 
appropriate. Modifications were done on the final forms of the tool. The result of the pilot study confirmed 
that the study is feasible. 
 
2.7 Procedure: 
Every patient interviewed individually information related to the study was explained as well as all the 
previously mentioned ethical considerations, after agreement to participate in the study they asked to sign the 
consent. Then the questionnaire filled by the researcher through a structured interview while the participants 
were waiting in the waiting area before or after they met their oncologists. 
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2.8 Statistical Data Analysis: 
The data was coded and tabulated using a personal computer. Statistical Package for Social Science (SPSS) 
version 20 was used. Descriptive statistics were calculated on the use of specific CHA therapies. General linear 
regression analyses were conducted to examine the relationships between the number of individual types of 
CHA used and particular patient background characteristics (ie, age, marital status, education,  activity of daily 
living, and performance status), Multivariable logistic regression analysis and cross tabulation were used to 
examine the relationship between patient background characteristics and the use of CHA. 
 
3. Results 
3.1. Section: I: Description of the studied Sample demographic and the medical data.  
Table (1): Frequency and Percentage Distribution of Demographic & Medical Characteristics of the Study  
Sample (n=150) 
Demographic No. % 
Age 
18-30 
31-44 
45-59 
60 or more 
 
35 
56 
53 
6 
 
23.3 
37.3 
35.3 
4.1 
Sex 
Male 
Female 
 
92 
58 
 
61.3 
38.7 
Education level          
Cannot read &write                                        
 Primary     
 Secondary            
 University  
 
16 
36 
26 
72 
 
10.7 
24.0 
17.3 
48.0 
Diagnosis  
Lung 
Brest  
Hepatobiliary 
Genitourinary  
Gastrointestinal 
Blood  
Others  
 
12 
28 
5 
14 
54 
25 
12 
 
8.0 
18.7 
3.3 
9.3 
36.0 
16.7 
8.0 
Duration of disease   
less than one year 
one to three years 
from three to five  years 
more than 5years 
 
18 
31 
47 
54 
 
12.0 
20.7 
31.3 
36.0 
Activity of daily living 
not specified 
limited  
bed rest more than 50%  
bed rest all the day    
 
41 
50 
27 
32 
 
27.3 
33.3 
18.1 
21.3 
Table (1) depicted that more than one third of the study sample (37.3%) their age ranges from 31-44, around two 
thirds (61.3%) of the study sample were males. Nearly half of them (48.0%) were graduated from university. 
Gastrointestinal cancer was the most prevalent cancer among study participants (36.0%). Regarding duration of 
disease about (36.0%) having cancer more than five years, about (33.3%) had limited activity of daily living. 
 
Section II: describing the use, predictors of complementary health approaches and characteristics of 
users among patients with cancer. 
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Table (2): Frequency Distribution of the Study Sample Regarding Treatment Used (n=150) 
Item No. % 
Type of treatment from the start of the disease 
Surgery 
chemotherapy  
hormonal  
radiotherapy  
palliative  
others   
 
21 
70 
18 
27 
8 
6 
 
14.0 
46.7 
12.0 
18.0 
5.3 
4.0 
Type of treatment you take now 
surgery 
chemo 
hormonal 
radio 
palliative 
others 
 
10 
83 
10 
37 
9 
1 
 
6.7 
55.3 
6.7 
24.7 
6.0 
.6 
Is the treatment effective  
Yes 
No 
 
78 
72 
 
52.0 
48.0 
Change in outlook in life 
Yes 
no     
 
81 
69 
 
54.0 
46.0 
Table (2) indicated that (46.7%) received chemotherapy from the start of the disease, while half of the study 
sample (55.3 %) receiving chemotherapy at the time. Almost half of them (52.0%) mentioned that the treatment 
were effective; and more than half (54.0%) had change in outlook in life. 
 
Table(3):Frequency Distribution of the Study Sample Regarding Characteristics of CHA Use (n=101) 
Item No. % 
Use of CHA 
yes 
no      
 
101 
49 
 
67.3 
32.7 
when you start to use it 
months 
years     
 
40 
61 
 
27.3 
40.0 
Motive for starting CHA   
advice from friends and family 
my desire 
the oncologist 
 
39 
55 
7 
 
38.6 
54.5 
6.9 
do you tell your Dr. about using CHA 
yes 
no     
 
19 
82 
 
18.8 
81.2 
Do you receive information about its effectiveness 
yes 
no      
 
25 
76 
 
24.8 
75.2 
Is disease costly 
yes 
no     
 
57 
42 
 
57.6 
42.4 
Does it promote its desired effect 
yes 
no 
I don’t know    
 
70 
15 
16 
 
69.3 
14.9 
15.8 
Side effects 
yes 
no      
 
17 
84 
 
16.8 
83.2 
Dr. response 
encourage me to continue  
ask me to stop  
no response     
 
58 
32 
11 
 
57.4 
31.7 
10.9 
Consulted with doctors about CHA use 
Yes 
no      
 
19 
82 
 
18.8 
81.2 
Table (3) enlightens that more than two thirds (67.3%) of the study sample were using CHA, about (40.0%) of 
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them using CHA for years. As regard the motives for using CHA more than half of the study sample (54.5%) is 
using it because this is their desire. Also most of them (81.2%) didn’t tell their oncologists about using CHA, 
(75.2%) didn’t receive any information about using CHA. More than half (57.6%) of the study sample 
considered the disease costly, in addition (69.3%) agreed that it promotes its desired effect , (83.2%) mentioned  
that it had no side effect. As regard doctor response of using CHA almost (57.4%) stated that the oncologists 
encourage them to continue moreover, (81.2%) doesn't consult the oncologist about using CHA. 
 
 
Figure (1): Frequency Distribution of the Study Sample as Regard Types of Used CHA (n=101) 
It is apparent from Figure (1) that the most frequent types of CHA used by the study sample were massage, 
herbal products and meditation (17.8 % 17.8% and16.8%) respectively. 
Table(4): CrossTabulation of Study Sample Using CHA: Characteristics of CHA Users (n=101) and Non-
CHA Users (n=49) 
items 
do you use CHA 
Total 
Chi P-value 
yes No 
15.741 0.001 
Age 
18-30 30 5 35 
31-44 42 14 56 
45-59 26 27 53 
60 and more 3 3 6 
 Duration of 
disease  
Less than one year 0 3 3 6.310 .012 
More than one year 101 46 147 
 
 
diagnosis 
 
 
lung  7 5 12 
15.787 0.015 
breast 19 9 28 
hepatobilliary 5 0 5 
genitourinary 11 3 14 
gastrointestinal 33 21 54 
blood 22 3 25 
others 4 8 12 
 
activity of 
daily living   
not specified 23 18 41 
8.066 0.045 
limited with little symptom 39 11 50 
bed rest more than 50% 21 6 27 
bed rest all the day 18 14 32 
 
date of 
disease  
less than one year 8 10 18 
5.497 0.139 
one to three years 23 8 31 
from three to five  years 34 13 47 
more than 5years 36 18 54 
*P-value ≤ 0.05 
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Table (4) explains that there is a significant relationships between age, diagnosis and activity of daily living and 
the use of CHA, in which younger age using CHA more frequently than older, on the other hand patient with 
genitourinary and blood cancer were using CAM more than others, While, patient with limited and decreased 
activity of daily living were the most users of CHA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (2): Comparison of the CHA Users and Nonusers in Relation to Gender (n= 150). 
As can be seen from figure (2) CHA use is greater among male than female cancer patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (3): Comparison of the CHA Users and Nonusers in Relation to Education (n=150). 
Figure (3) portrays that CHA use is greater among highly educated people. 
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Table (4): Predictors of CHA Use Using Multivariate logistic Regression Analysis: 
Variables P value Odds 
Ratio 
95 % CI for Odds 
Ratio 
Lower Upper 
age .010* 4.970 1.465 16.866 
sex .241 .600 .255 1.410 
education .242 2.224 .582 8.497 
duration of disease .999 .000 .000 .000 
date of disease .061 .311 .091 1.058 
diagnosis .354 .504 .118 2.149 
activity of daily living .033* .346 .130 .916 
type of treatment from the start of the disease .418 .621 .196 1.969 
type of treatment you take now .133 .311 .068 1.428 
treatment effective .089 2.158 .889 5.236 
change in outlook in life .076 2.106 .925 4.796 
*P-value ≤ 0.05 
Table (4) discloses that the significant predictors of CHA use using multivariate logistic regression analysis were 
found to be age (p value=0.010), and activity of daily living (p value=0.033). Young age (18-30) increases CHA 
use by 4.9 times than older ages. Limited and decreased activity of daily living increases CHA use by .346 times. 
 
4. Discussion 
The use of CHA in cancer patients with conventional treatments such as chemotherapy, radiation and surgery is 
growing over the past 15 years, not only in Western countries, but also in the Far East or in developing countries. 
So it has undoubtedly gained medical, economic and research importance (Rossi et al., 2015, Kessel et al., 
2016). Nevertheless the literature about CHA prevalence in cancer patients is not particularly rich. Many patients 
do not declare that they engage in this practice, on one hand because they undervalue the potential interaction of 
these therapies with the conventional drugs, and, on the other hand, because they are somehow reluctant to admit 
the use of CHA, worrying that such behavior may be interpreted as reflecting a loss of trust in oncologist and the 
treatment has prescribed (Berretta et al., 2017). 
 
The study on hand shed the light on that more than two thirds of the study sample were using CHA in 
combination with the conventional treatment of cancer. This figure is approximately near to previously reported 
figures from other countries like Korea (78.5%), Scotland (55%) and Switzerland (53%) (Rossi et al., 2015). 
In a survey done by King et al.,(2015) approximately 47% of cancer patients have reported the use of various 
CHA. The largest survey in Europe on the use of CHA in cancer patients showed that , more than one third of 
cancer patients reported using some form of CHA, with little variation across countries (Rossi et al., 2015). An 
Egyptian study showed that 23% of the studied cancer patients received CHA. Scarcity of previous studies 
conducted in Egypt on prevalence of CHA hinders comparing and tracing the trend of CHA use (Abdelmoaty 
et al., 2018). The noted difference of CHA utilization rate between several studies could be most likely due to 
multiple factors such as the lack of standardized definitions and methods utilized to assess CHA usage, 
differences in culture, socioeconomic condition, and/or study methodology itself. 
 
The most frequent CHA used by the current study sample were herbs, massage and meditation, where nearly one 
fifth of them used these modalities. This is in line with Fremd et al. (2017) who stressed that across many 
countries, herbals, homeopathy, relaxation techniques like massage, prayer as well as food supplements and 
vitamins are most popular CHA used strategies among German patients with breast cancer. El Nimr, Wahdan, 
Wahdan, & Kotb (2015)) investigated the prevalence of complementary and alternative medicines in Alexandria, 
Egypt reported that the most frequently used CHA in general population not specifically in cancer were herbs 
(91.6%), followed by spiritual healing (9.4%) and cupping and acupuncture (6.4%).  
 
According to the study by Rossi et al., exploring the use of CHA in Italian cancer patients in six cancer 
departments, 37.9% of patients use one or more types of CHA: diet and food supplements (27.5%), herbal 
medicine (10.8%), homeopathy (6.4%) and body-mind therapies (5.5%); a high percentage of patients (66.3%) 
also inform the physicians of this choice and the benefits they experience (89.6%)(Rossi, Di Stefano, Firenzuoli, 
Monechi, & Baccetti, 2017). The most popular modalities of CHA used for cancer-related outcomes were herbal 
medicine (32.9%), mind-body therapies (29.4%) as reported in a study examined the complementary and 
alternative medicine use among patients with cancer in Mongolia (Oyunchimeg, Hwang, Ahmed, Choi, & Han, 
2017). Alongside the traditional use of herbs, it is possible today to use herbal medicine in trials based on 
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documented clinical evidence, generally to relieve the most common symptoms, when these prove to be drug 
resistant (Rossi et al., 2017). 
 
Regarding characteristics of the study sample using CHA, the findings of the present study exhibited that more 
than one third of them using CHA for years. As regard the motives for using CHA, more than half of the study 
sample was using CHA according to their own preferences. Also the vast majority of them neither consult nor 
telling their oncologists about using CHA and stated that it promotes its desired effect with more than two thirds 
of them reported no side effects. The majority of the study sample didn’t receive any information regarding CHA 
from health care providers. As regard doctor response of using CHA more than half of the study sample stated 
that the oncologists encourage them to continue. 
 
The majority of users believed that CHA was effective. However, it is difficult to say whether these 
improvements were related to use of CHA, since all patients received conventional cancer treatment at the same 
time. Similar to past studies, a relatively small proportion of CHA users made their doctors aware of their 
decision to use CHA. This could be dangerous, specifically in the area of oncology, where treatment methods 
and procedures are becoming more and more advanced. The risk of interaction between patients’ use of CHA by 
their own decision and conventional treatment might jeopardize their life, as evidence suggests that consumption 
of complementary therapy can have negative effects when used concurrently with conventional radiotherapy 
and/or chemotherapy. Therefore, it is recommended that clinicians and nurses should be more aware of patients’ 
health care behavior (Oyunchimeg et al., 2017). 
 
On the contrary to our results Suzuki et al. (2017) found that the main motive for CHA use was the 
recommendation of family members or friends. The population of patients who were willing to seek out CHA on 
their own was unexpectedly small, about one fourth of the users. In congruent with the current study findings the 
latter authors reported that most cancer patients use CHA without any harmful influence on their cancer 
treatment; however, in some patients, CHA incurs a large expense and a delay in starting cancer treatment.  
 
Cross tabulation of the current study sample to examine the characteristics of CHA users and non-CHA users 
revealed that there are significant relationships between age, sex, education, diagnosis and activity of daily living 
and the use of CHA, in which younger age using CHA more frequently than older, CHA use is greater among 
male than females. CHA use is greater among highly educated patients. On the other hand people with 
genitourinary and blood cancer were using CHA more than others. Patients with limited and decreased activity 
of daily living were the most users of CHA. 
 
In view of the existing study findings and in line with findings of previous studies where younger age, higher 
level of education were associated with CHA use (Oyunchimeg et al., 2017). Another study proposed that CHA 
users differed from non CHA users based on their age (more likely to be younger or middle aged), gender 
(female), level of education (college degree or higher) (Kemppainen, Kemppainen, Reippainen, Salmenniemi, & 
Vuolanto, 2018), cancer diagnosis (breast or ovarian) (Sohl et al., 2014).The researchers justify the use of CHA 
by educated patients by that probably a high education level allows easier access to the media, internet and 
information about medicine. 
 
 In accord to our results the authors reported that males were discerning in their evaluation of CHA information, 
offered rationales for their choices and often adopted a 'consumerist' approach to CHA treatment options(Evans 
et al., 2007). Most studies have shown that either younger patients <40 years of age or retirees significantly more 
often use CHA. Females are significantly more often open to CHA than males, opposing our results. However, 
some studies have not confirmed this higher prevalence in women or in patients with higher education (Kessel et 
al., 2016). The European survey published by Molassiotis et al. included 956 patients from fourteen countries 
described that despite suggestions from the literature that breast cancer patients are more likely to use CHA 
compared with other cancer patients, the study showed that pancreatic, liver, bone and brain cancer patients used 
CHA therapies significantly more often than any other cancer patient group (Molassiotis et al., 2005). 
 
Predictors of higher CHA use by patients with cancer in the current study were age and the activity of daily 
living, where younger participants and those with decreased activity of daily living were more likely to use 
CHA. 
 
The researchers could explains these findings in the light of the fact that younger participants and those who are  
with decreased activity of daily living sought a mean rather than conventional treatment, one aspect is the 
common belief that different methods of CHA have the potential to boost the immune system and to strengthen 
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the body to fight cancer. Therefore it will help them to improve their general wellbeing. 
 
In a study done by Anderson & Taylor found that predictors of higher CHA use by patients with cancer were 
female gender, stage of disease at diagnosis, age, higher education, higher income, race, and geographical 
location (Anderson & Taylor, 2012). Regarding our study results revealed that age, gender, level of education, 
diagnosis were not predictors to CHA use but considered only significant characteristics of CHA users. Similar 
to our result (Bahall, 2017) clarified that CHA use was associated with age, but no predictors of CHA use could 
be identified.  
 
In contrary to our  study findings (El Nimr et al., 2015)revealed that age, occupation and the presence of chronic 
conditions were the independent factors significantly predicting the practice of self-medication and CHA usage. 
Moreover Suzuki et al.(2017)showed that CHA use is significantly associated with younger patients and highly 
educated families. This holds true in multivariate analysis done by (Fremd et al., 2017)and confirmed the 
patient’s age as predictive for interest in CHA. Berretta et al.(2017) study demonstrated that a higher functional 
status (less impairment with activities of daily living, was predictive of CHA use with no difference was noticed 
between males and females.  
 
Altogether, Use of unconventional therapies is pervasive among cancer patients, particularly among those who 
are younger and highly educated. Oncology providers need to assess patients’ complementary therapy use and 
consider potential interactions with prescribed treatment protocols. 
 
5. Conclusion 
Complementary health approach appears to be widely accepted by patients with cancer in the study sample. 
Health care providers especially oncology nurse should take the initiative to ask whether patients are using any 
CHA, so they can provide evidence-based consultation concerning the appropriateness of using CHA during 
conventional cancer treatment. The findings support the urgent need. High CHA use among patients with cancer 
in our study warrants further studies in other countries of this region. 
 
6. Recommendations of the Study 
Based on the study results, the following recommendations were suggested: 
1. Further in-depth study into commonly used CHA products and their potential effects on health of 
cancer population in Egypt. 
2. Replication of this study among a larger sample from various settings is requested to generalize 
the results. 
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